UnicoCell Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	49.51	9.57	19.9	53.64	130.85	222.02
Short-Term Investments	534.59	518.37	457.38	160.25	10.17	10.09
Trading Asset Securities	13.17	22.3	-	-	-	-
Cash & Short-Term Investments	597.27	550.24	477.28	213.89	141.02	232.11
Cash Growth	-1.04%	15.29%	123.15%	51.67%	-39.24%	1.40%
Accounts Receivable	1.36	2.81	2.08	1.38	0.4	0.75
Other Receivables	17.65	19.6	18.08	13.47	12.02	0.11
Receivables	19.01	22.41	20.16	14.84	12.42	0.87
Inventory	9.21	9.75	7.5	7.98	7.83	4.01
Prepaid Expenses	2.64	3.66	1.61	1.13	2.04	14.41
Other Current Assets	2.82	6.29	0.24	0.06	-	0
Total Current Assets	630.95	592.35	506.8	237.9	163.31	251.4
Property, Plant & Equipment	142.55	152.59	175.89	173.36	131.21	132.35
Long-Term Investments	29	29	-	-	-	-
Other Intangible Assets	0.34	0.34	0.33	0.36	0.4	0.78
Other Long-Term Assets	3.29	3.61	2.92	2.7	2.8	6.7
Total Assets	806.14	777.89	685.93	414.31	297.71	391.22
Accounts Payable	0.98	1.97	0.11	0.91	0.08	0.51
Current Portion of Leases	6.32	6.22	6.09	5.93	8.95	10.11
Current Unearned Revenue	0.5	6.62	0.02	1.52	-	-
Other Current Liabilities	10.74	12.32	10.68	8.18	12.34	12.6
Total Current Liabilities	18.54	27.13	16.9	16.54	21.37	23.22
Long-Term Leases	57.27	62.02	68.24	60.66	12.63	23.88
Other Long-Term Liabilities	4.18	4.13	4.35	3.26	0.71	0.71
Total Liabilities	79.98	93.28	89.49	80.46	34.71	47.81
Common Stock	606.79	584.11	556.85	423.61	377.75	375.7
Additional Paid-In Capital	809.82	705.87	551.89	338.43	222.29	218.37
Retained Earnings	-690.46	-605.37	-512.29	-428.19	-337.03	-250.66
Shareholders' Equity	726.16	684.61	596.44	333.85	263.01	343.41
Total Liabilities & Equity	806.14	777.89	685.93	414.31	297.71	391.22
Total Debt	63.58	68.24	74.33	66.59	21.58	33.99
Net Cash (Debt)	533.69	482.01	402.95	147.3	119.44	198.12
Net Cash Growth	-0.01%	19.62%	173.56%	23.32%	-39.71%	7.53%
Net Cash Per Share	8.94	8.40	7.49	3.55	3.17	5.58
Filing Date Shares Outstanding	60.68	58.41	55.69	42.36	37.78	37.57
Total Common Shares Outstanding	60.68	58.41	55.69	42.36	37.78	37.57
Working Capital	612.42	565.22	489.9	221.36	141.94	228.18
Book Value Per Share	11.97	11.72	10.71	7.88	6.96	9.14
Tangible Book Value	725.82	684.27	596.12	333.5	262.61	342.63
Tangible Book Value Per Share	11.96	11.71	10.71	7.87	6.95	9.12
Machinery	73.95	70	67.02	65.56	60.92	49.91
Construction In Progress	-	-	-	-	68.3	52.22
Leasehold Improvements	99.39	98.28	97.5	93.25	16.35	16.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.